HopeStage
Back to all studies
TerminatedNCT05335980

Nu-V3 Non-Invasive Nerve Stimulation Device Trial for Chronic Pain, Anxiety, Depression, Sleeplessness

Device studyAges 18+United States
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
PhoenixSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 13, 2018
Recruitment status
Terminated
Enrollment listed in the registry
16
Sponsor
Nu-Life Solutions
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT05335980
Official title
Show the full official title

A Phase II Prospective, Single-Arm, Open-Label, Multi-Center Study Using the Nu-V3 Cranial Nerve Stimulation Treatment Device in Patients With Chronic Pain, Anxiety, Depression, and/or Sleeplessness

Recruitment & locations

Terminated

Phoenix

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Nu-Life Solutions.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies